Workflow
亿帆医药: 独立董事提名人声明与承诺(刘梅娟)

Core Viewpoint - Yifan Pharmaceutical Co., Ltd. has nominated Liu Meijuan as a candidate for the independent director of its ninth board of directors, ensuring compliance with relevant regulations and qualifications for independent directors [1][8]. Summary by Sections Nomination Process - The nomination of Liu Meijuan was made after a thorough review of her professional background, education, qualifications, and any potential conflicts of interest [1]. - The nominee has agreed in writing to serve as an independent director candidate [1]. Compliance with Regulations - The nominee meets the qualifications and independence requirements set forth by the Company Law of the People's Republic of China and the Shenzhen Stock Exchange [1][2]. - The nominee has participated in training and obtained relevant certification recognized by the stock exchange [2]. Independence Assurance - The nominee does not have any close relationships that could affect her independent performance [1]. - The nominee and her immediate family do not hold more than 1% of the company's issued shares and are not part of the top ten shareholders [5][6]. Commitment to Responsibilities - The nominator guarantees the truthfulness and completeness of the statements made regarding the nominee's qualifications [8]. - The nominator commits to report any changes in the nominee's independence status during her tenure as an independent director [8].